Dr. Maddrey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-645-0624Fax+1 214-645-0078
Education & Training
- Johns Hopkins UniversityResidency, Internal Medicine, 1968 - 1970
- Johns Hopkins UniversityResidency, Internal Medicine, 1964 - 1966
- Johns Hopkins University School of MedicineClass of 1964
- Wake Forest UniversityB.S., Summa Cum Laude, 1956 - 1960
Certifications & Licensure
- TX State Medical License 1991 - 2025
- PA State Medical License 1982 - 2006
- MD State Medical License 1970 - 1991
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Henry Strong Denison Scholar in the Medical Sciences
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Distinguished Alumnus Award The Johns Hopkins University School of Medicine, 2009
- Join now to see all
Publications & Presentations
PubMed
- 138 citationsCorticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo—a Meta-analysis of Individual...Alexandre Louvet, Mark Thursz, Dong Joon Kim, Julien Labreuche, Stephen R. Atkinson
Gastroenterology. 2018-08-01 - 642 citationsCorticosteroid therapy of alcoholic hepatitisWillis C. Maddrey, John K. Boitnott, Marshall Bedine, Fredrick L. Weber, Esteban Mezey
Gastroenterology. 1978-08-01 - 548 citationsComparison of Lactulose and Neomycin in the Treatment of Chronic Portal-Systemic Encephalopathy: A double blind controlled trialH. O. Conn, C. M. Leevy, Z. R. Vlahcevic, J. B. Rodgers, Willis C. Maddrey
Gastroenterology. 1977-04-01
Journal Articles
- Efficacy, safety and clinical pharmacology of macitentan in comparison to other endothelin receptor antagonists in the treatment of pulmonary arterial hypertensionDingemanse J1, Sidharta PN, Maddrey WC, Rubin LJ, Mickail H, Expert Opinion On Drug Safety, 1/1/2014
- Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient dataCL., Ramond MJ., Naveau S., Maddrey WC., Morgan TRMathurin P., O’Grady J., Carithers RL.,Phillips M., Louvet A., Mendenhall, Gut, 1/1/2011
- Evaluation of Drug-Induced Serious Hepatotoxicity (eDISH) Application of this Data Organization Approach to Phase III Clinical Trials of Rivaroxaban after Total Hip or...Watkins, P.B., M. Desai, S. D. Berkowitz, G. Peters, Y. Horsmans, D. Larrey, and W. Maddrey, Drug Safety, 1/1/2011
- Join now to see all
Books/Book Chapters
Lectures
- 27th Annual New Treatments in Chronic Liver DiseaseScripps Conference Services & CME /Scripps Translational Science Institute (STSI), San Diego, Califo - 3/31/2012
- 40th Annual USC Diagnostic & Therapeutic Skills in Internal MedicineUniversity of Southern California, Maui, Hawaii - 3/12/2012
- Liver TransplantationAustralia - 1/1/1990
- Join now to see all
Press Mentions
- Liver Transplant Survivor’s Recovery Linked to Sociodemographic Factors, UTSW Study ShowsApril 26th, 2023
- UT Southwestern Nephrologist Addresses National Kidney FoundationApril 12th, 2023
- The Origins of the Modern‐Day Study of Drug Hepatotoxicity: Focus on Hyman J. ZimmermanMarch 2nd, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: